|
Drugs
Citations 1-10 of 19 total displayed.
|
Most recent content
(2 Dec 2008):
|
- Commentary
Can studies of harm be harmful?
- Joel G. Ray, MD MSc
Can. Med. Assoc. J. 2008; 179: 1243-1244.
[Full text]
[PDF]
- Research
Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes
- Shi Wu Wen, MB PhD, Jia Zhou, MB MSc, Qiuying Yang, MD PhD, William Fraser, MD MSc, Olufemi Olatunbosun, MD, and Mark Walker, MSc MD
Can. Med. Assoc. J. 2008; 179: 1263-1268.
[Abstract]
[Full text]
[PDF]
[ Résumé ] [ Online Appendices ]
|
Past content
(since Oct 2001):
|
- News
Manitoba pharmacists' association clarifies Plan B regulations
- Laura Eggertson
Can. Med. Assoc. J. 2006; 174: 1078.
[Full text]
[PDF]
- Practice
WinRho and disseminated intravascular coagulopathy
- Claire Kendall and Eric Wooltorton
Can. Med. Assoc. J. 2006; 174: 767-768.
[Full text]
[PDF]
- Letters
Summary Basis of Decision in context
- Joel Lexchin and Barbara Mintzes
Can. Med. Assoc. J. 2005; 172: 1664-a-1665-a.
[Full text]
[PDF]
- Letters
Summary Basis of Decision in context
- Diane Gorman
Can. Med. Assoc. J. 2005; 172: 1664.
[Full text]
[PDF]
- Letters
Complexity of risk determination
- Mark Latowsky
Can. Med. Assoc. J. 2005; 172: 309.
[Full text]
[PDF]
- Letters
Neural tube defects
- Fu-Lin Wang, Hude Quan, and Donald Schopflocher
Can. Med. Assoc. J. 2005; 172: 158.
[Full text]
[PDF]
- Commentary
Transparency in drug regulation: Mirage or oasis?
- Joel Lexchin and Barbara Mintzes
Can. Med. Assoc. J. 2004; 171: 1363-1365.
[Full text]
[PDF]
- Synopsis
New directions in drug approval
- Joel Lexchin
Can. Med. Assoc. J. 2004; 171: 229-230.
[Full text]
[PDF]
|
|
